Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...

A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target ...